Central Diabetes Insipidus

• FDA approval · 2017-08-22
  FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sagent Pharmaceuticals)

  FDA approved an original application for Desmopressin Acetate from Sagent Pharmaceuticals, establishing a generic version of the product.

• FDA approval · 2017-05-26
  FDA Approved: DESMOPRESSIN ACETATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA approved an Original Application for Desmopressin Acetate as a generic product manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet …

• FDA approval · 2016-12-17
  FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)

  FDA approved a supplemental application for Vasostrict (vasopressin) submitted by Par Health USA, LLC. This action concerns the approval of …

• FDA approval · 2015-05-28
  FDA Approved: DESMOPRESSIN ACETATE — Original Application (Glenmark Pharmaceuticals Inc.,USA)

  The FDA approved Glenmark's Desmopressin Acetate as an Original Application (ANDA201831), authorizing the generic product to be marketed for…

• FDA approval · 2015-01-23
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp. under an ANDA.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2015-01-14
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Bauch & Lomb Incorporated)

  FDA approved a supplemental application for desmopressin acetate from Bauch & Lomb Incorporated under an ANDA.

• FDA approval · 2014-02-28
  FDA Approved: DDAVP — Supplemental Application (Ferring Pharmaceuticals Inc.)

  The FDA approved a supplemental application for DDAVP (desmopressin acetate) filed by Ferring Pharmaceuticals Inc. The action updates the pr…

• CLINICAL_TRIALS trial_result · 2012-08-13
  Clinical Trial Update: A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI). [Phase 3]

  A Phase 3 clinical trial evaluating Minirin Melt (desmopressin) in Japanese patients with Central Diabetes Insipidus is reported. The study …

• FDA approval · 2009-03-27
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

  FDA approved a supplemental application for Desmopressin Acetate submitted by Meitheal Pharmaceuticals Inc.

• FDA approval · 2008-09-03
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp., indicating an addition or modification to the approved p…

• FDA approval · 2007-10-26
  FDA Approved: DDAVP — Supplemental Application (Ferring Pharmaceuticals Inc.)

  FDA approved a supplemental application for DDAVP (desmopressin acetate) from Ferring Pharmaceuticals Inc., updating the product's labeling.

• FDA approval · 2007-05-23
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for Desmopressin Acetate submitted by Apotex Corp. under an ANDA.

• FDA approval · 2006-12-03
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)

  FDA granted a supplemental approval for Desmopressin Acetate from Apotex Corp. under an ANDA, authorizing its generic product.